Skip to main content

Advertisement

Fig. 1 | Journal of Translational Medicine

Fig. 1

From: High expression of the human equilibrative nucleoside transporter 1 gene predicts a good response to decitabine in patients with myelodysplastic syndrome

Fig. 1

Comparison of hENT1, hENT2, DCK, and CDA expression levels between responders and non-responders; CR and non-CR; CCR and non-CCR. a Increased hENT1 in responders compared to non-responders. hENT2, DCK, and CDA mRNA expression levels did not differ between responders and non-responders. b Elevated hENT1 level in CR patients compared to non-CR patients. No significant difference of hENT2, DCK, and CDA mRNA level between CR and non-CR patients. c Increased hENT1 rather than hENT2, DCK, or CDA level in CCR patients compared to non-CCR patients

Back to article page